Avermectins and milbemycins against Fasciola hepatica: In vivo drug efficacy and in Vitro receptor binding
Authors:
- D.A. OstlindDOD.A. Ostlind
- S.P. RohrerSRS.P. Rohrer
- G. MickleGMG. Mickle
- H.W. HainesHHH.W. Haines
- B.F. MichaelBMB.F. Michael
- H. MrozikHMH. Mrozik
- M.H. FisherMFM.H. Fisher
- 1 August 1995
- journal article
- Published by Elsevier in International Journal for Parasitology
- Vol. 25 (8) , 923-927
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Identification of neuron-specific ivermectin binding sites in Drosophila melanogaster and Schistocerca americanaInsect Biochemistry and Molecular Biology, 1995
- Ivermectin Binding Sites in Sensitive and Resistant Haemonchus contortusJournal of Parasitology, 1994
- Comparative efficacy of moxidectin, an ivermectin/clorsulon combination and closantel against immature paramphistomes in cattleAustralian Veterinary Journal, 1993
- Avermectin binding in Caenorhabditis elegansBiochemical Pharmacology, 1989
- Fasciola hepaticainfection in micePathogens and Global Health, 1981
- The chemotherapeutic activity of selected fasciolicides against immatureFasciola hepatica in miceCellular and Molecular Life Sciences, 1973
- Murine Fascioliasis: Laboratory Model for the Detection of Fasciolicidal Activity of Chemical CompoundsJournal of Parasitology, 1973